Your search for Regulatory Science Symposium: Diversity in Clinical Trials in the Time of COVID-19 returned the following most recent results.

Online Educational Library View only Online Educational Library results

Regulatory Science Symposium: Diversity in Clinical Trials in the Time of COVID-19 Session 1: Introduction

regulatory & quality sciences

Regulatory Science Symposium: Diversity in Clinical Trials in the Time of COVID-19 Session 5: Diversity, Equity and Inclusion in Clinical Research

research & study design, regulatory & quality sciences

Regulatory Science Symposium: Diversity in Clinical Trials in the Time of COVID-19 Session 3: FDA Initiatives to Address Diversity in Clinical Trials

regulatory & quality sciences

Regulatory Science Symposium: Diversity in Clinical Trials in the Time of COVID-19 Session 6: Populations on the Fringe of Clinical Trial Enrollment

research & study design, regulatory & quality sciences

Regulatory Science Symposium: Diversity in Clinical Trials in the Time of COVID-19 Session 2: What Do We Mean by Diversity in Clinical Trials?

research & study design, regulatory & quality sciences

Regulatory Science Symposium: Diversity in Clinical Trials in the Time of COVID-19 Session 7: Ensuring Participant Diversity and Engagement During COVID-19

research & study design, regulatory & quality sciences

NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.